HomeMEIP • NASDAQ
MEI Pharma Inc
Follow
Market news
.INX
5.97%
Financials
Income Statement
Revenue
Net Income
Revenue
Net income
(USD) | Dec 2024info | Y/Y change |
---|---|---|
Revenue | — | — |
Operating expense | 2.19M | -72.44% |
Net income | -2.68M | 75.80% |
Net profit margin | — | — |
Earnings per share | — | — |
EBITDA | -2.25M | 80.50% |
Effective tax rate | — | — |
Balance Sheet
Total Assets
Total Liabilities
Total assets
Total liabilities
(USD) | Dec 2024info | Y/Y change |
---|---|---|
Cash and short-term investments | 23.74M | -60.09% |
Total assets | 24.39M | -68.95% |
Total liabilities | 2.29M | -87.99% |
Total equity | 22.10M | — |
Shares outstanding | 6.66M | — |
Price to book | 0.64 | — |
Return on assets | -21.59% | — |
Return on capital | -23.96% | — |
Cash Flow
Net Change in Cash
Net change in cash
(USD) | Dec 2024info | Y/Y change |
---|---|---|
Net income | -2.68M | 75.80% |
Cash from operations | -3.67M | 66.84% |
Cash from investing | 20.45M | -16.58% |
Cash from financing | — | — |
Net change in cash | 16.79M | 831.58% |
Free cash flow | -1.90M | 73.96% |
Previous close
$2.13
Day range
$1.90 - $2.13
Year range
$1.90 - $4.10
Market cap
13.33M USD
Avg Volume
8.16K
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
About
Founded
2000
Website
Employees
28